Literature DB >> 33398670

Capsular Invasion Matters Also in "Papillary Patterned" Tumors: A Study on 121 Cases of Encapsulated Conventional Variant of Papillary Thyroid Carcinoma.

Dilara Akbulut1, Ezgi Dicle Kuz1, Nazmiye Kursun2, Serpil Dizbay Sak3.   

Abstract

Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy. Some PTCs with classical papillae can be totally or partially encapsulated, and these tumors are called "encapsulated" (conventional) variant of papillary thyroid carcinoma. We aimed to investigate the clinicopathological features of this variant, comparing with non-encapsulated conventional type PTC. Among 823 thyroidectomy specimens with PTC diagnosed between 2015 and 2018, 121 tumors from 105 patients (12.75%) were reclassified as encapsulated conventional PTC. In 76 patients, tumors were unifocal. Size, cystic changes, background thyroiditis, psammoma bodies, cervical lymph node metastasis at presentation, capsular/vascular invasion, and immunohistochemical BRAF-V600E expression were evaluated. Ninety-two non-encapsulated conventional PTCs served as control group. Encapsulated cases were predominantly women (73.3%), 56.4% were microcarcinomas, 97.5% had cystic changes, 81.4% were BRAF-V600E positive, and 36.8% of unifocal encapsulated tumors had cervical lymph node metastasis. Thyroiditis and psammoma bodies were detected in nearly half of the encapsulated PTCs. Fourteen percent of the unifocal tumors showed total encapsulation, whereas capsular and vascular invasion was detected in 85.5% and 5.8%, respectively. Encapsulated cases did not show any significant difference from the control group, except for prominent cystic changes (p < 0.001). Relationship between lymph node metastasis at presentation and capsular invasion was statistically significant (p = 0.001), and metastasis was more frequent in cases with extensive capsular invasion (no/minimal invasion versus extensive invasion, p < 0.001). Cystic changes are very common, and this feature deserves mentioning as a morphological characteristic of encapsulated conventional PTCs. As in encapsulated "follicular" variant of PTC, capsular invasion status is important in evaluating papillary patterned encapsulated PTC for predicting lymph node metastasis. Total examination of the tumor capsule and inclusion of capsular invasion status in pathology reports are recommended.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Capsular invasion; Encapsulated variant; Papillary thyroid carcinoma; Thyroid

Mesh:

Year:  2021        PMID: 33398670     DOI: 10.1007/s12022-020-09650-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  32 in total

1.  Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.

Authors:  Ian Ganly; Laura Wang; R Michael Tuttle; Nora Katabi; Gustavo A Ceballos; H Ruben Harach; Ronald Ghossein
Journal:  Hum Pathol       Date:  2015-02-04       Impact factor: 3.466

2.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

3.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

4.  Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.

Authors:  K Cupisti; N Lehwald; M Anlauf; J Riemer; T A Werner; A Krieg; J Witte; A Chanab; S E Baldus; M Krausch; A Raffel; C Herdter; M Schott; W T Knoefel
Journal:  Horm Metab Res       Date:  2013-12-19       Impact factor: 2.936

5.  Risk stratification of follicular variant of papillary thyroid carcinoma.

Authors:  Marina Vivero; Stefan Kraft; Justine A Barletta
Journal:  Thyroid       Date:  2013-03       Impact factor: 6.568

Review 6.  Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): impact on the reclassification of thyroid nodules.

Authors:  Isabel Amendoeira; Tiago Maia; Manuel Sobrinho-Simões
Journal:  Endocr Relat Cancer       Date:  2018-02-09       Impact factor: 5.678

7.  Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma.

Authors:  Simonetta Piana; Andrea Frasoldati; Enza Di Felice; Giorgio Gardini; Giovanni Tallini; Juan Rosai
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

8.  Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study.

Authors:  Zubair W Baloch; Khurram Shafique; Melina Flanagan; Virginia A Livolsi
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

9.  Encapsulated papillary neoplasms of the thyroid. A study of 14 cases followed for a minimum of 10 years.

Authors:  H L Evans
Journal:  Am J Surg Pathol       Date:  1987-08       Impact factor: 6.394

10.  Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).

Authors:  Michael Rivera; R Michael Tuttle; Snehal Patel; Ashok Shaha; Jatin P Shah; Ronald A Ghossein
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

View more
  3 in total

Review 1.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

2.  Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study.

Authors:  Liu Yihao; Li Shuo; Xi Pu; Wang Zipeng; Sun Hanlin; Chang Qungang; Wang Yongfei; Yin Detao
Journal:  Int J Endocrinol       Date:  2022-06-28       Impact factor: 2.803

3.  Radiomics Analysis of Computed Tomography for Prediction of Thyroid Capsule Invasion in Papillary Thyroid Carcinoma: A Multi-Classifier and Two-Center Study.

Authors:  Xinxin Wu; Pengyi Yu; Chuanliang Jia; Ning Mao; Kaili Che; Guan Li; Haicheng Zhang; Yakui Mou; Xicheng Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-25       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.